The CD200-CD200R1 Inhibitory Signaling Pathway. Immune Regulation and Host-Pathogen Interactions.

Advances in Immunology

Volumn 121, Issue , 2014, Pages 191-211

  Vaine, Christine A ^a   Soberman, Roy J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CD200; CD200R1; Inflammation; Inhibitory receptors; Pathogens; Viruses

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; CD200 RECEPTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; MESSENGER RNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CORONAVIRUS; CORONAVIRUS INFECTION; CYTOKINE RESPONSE; GENE EXPRESSION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LEISHMANIA; LEISHMANIASIS; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS REPLICATION; VIRUS VIRULENCE;

CD200; CD200R1; INFLAMMATION; INHIBITORY RECEPTORS; PATHOGENS; VIRUSES;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; EXTRACELLULAR FLUID; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; INFLUENZA, HUMAN; LECTINS, C-TYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, CELL SURFACE; RECEPTORS, KIR; SIGNAL TRANSDUCTION;

EID: 84891357479     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800100-4.00005-2     Document Type: Chapter

References (73)

1. Adams S., van der Laan L.J., Vernon-Wilson E., Renardel de Lavalette C., Dopp E.A., Dijkstra C.D., et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. Journal of Immunology 1998, 161:1853.
2. Alblas J., Honing H., de Lavalette C.R., Brown M.H., Dijkstra C.D., van den Berg T.K. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Molecular and Cellular Biology 2005, 25:7181.
3. Arase H., Lanier L.L. Specific recognition of virus-infected cells by paired NK receptors. Reviews in Medical Virology 2004, 14:83.
4. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323.
5. Barclay A.N., Brown M.H. The SIRP family of receptors and immune regulation. Nature Reviews. Immunology 2006, 6:457.
6. Bhatnagar S., Shinagawa K., Castellino F.J., Schorey J.S. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007, 110:3234.
7. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Journal of Immunology 1999, 162:305.
8. Cameron C.M., Barrett J.W., Liu L., Lucas A.R., McFadden G. Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. Journal of Virology 2005, 79:6052.
9. Cameron C.M., Barrett J.W., Mann M., Lucas A., McFadden G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 2005, 337:55.
10. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3527.
11. Caserta S., Nausch N., Sawtell A., Drummond R., Barr T., Macdonald A.S., et al. Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells. PLoS One 2012, 7:e35466.
12. Chapman T.L., Heikeman A.P., Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999, 11:603.
13. Chen Z., Marsden P.A., Gorczynski R.M. Cloning and characterization of the human CD200 promoter region. Molecular Immunology 2006, 43:579.
14. Chen Z., Marsden P.A., Gorczynski R.M. Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-gamma and tumor necrosis factor-alpha. Molecular Immunology 2009, 46:1951.
15. Chlewicki L.K., Velikovsky C.A., Balakrishnan V., Mariuzza R.A., Kumar V. Molecular basis of the dual functions of 2B4 (CD244). Journal of Immunology 2008, 180:8159.
16. Cortez M., Huynh C., Fernandes M.C., Kennedy K.A., Aderem A., Andrews N.W. Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand cd200. Cell Host & Microbe 2011, 9:463.
17. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997, 7:273.
18. Costello D.A., Lyons A., Denieffe S., Browne T.C., Cox F.F., Lynch M.A. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: A role for Toll-like receptor activation. The Journal of Biological Chemistry 2011, 286:34722.
19. Daeron M., Jaeger S., Du Pasquier L., Vivier E. Immunoreceptor tyrosine-based inhibition motifs: A quest in the past and future. Immunological Reviews 2008, 224:11.
20. De Albuquerque N., Baig E., Ma X., Zhang J., He W., Rowe A., et al. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. Journal of Virology 2006, 80:10382.
21. Debierre-Grockiego F., Campos M.A., Azzouz N., Schmidt J., Bieker U., Resende M.G., et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. Journal of Immunology 2007, 179:1129.
22. Deckert M., Sedgwick J.D., Fischer E., Schluter D. Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathologica 2006, 111:548.
23. Dentesano G., Straccia M., Ejarque-Ortiz A., Tusell J.M., Serratosa J., Saura J., et al. Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells. Journal of Neuroinflammation 2012, 9:165.
24. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997, 386:510.
25. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972.
26. Foster-Cuevas M., Westerholt T., Ahmed M., Brown M.H., Barclay A.N., Voigt S. The cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor. Journal of Virology 2011, 85:6055-6059.
27. Foster-Cuevas M., Wright G.J., Puklavec M.J., Brown M.H., Barclay A.N. Human herpesvirus 8K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. Journal of Virology 2004, 78:7667.
28. Gorczynski R.M. Transplant tolerance modifying antibody to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages. European Journal of Immunology 2001, 31:2331.
29. Goulding J., Godlee A., Vekaria S., Hilty M., Snelgrove R., Hussell T. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. The Journal of Infectious Diseases 2011, 204:1086.
30. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768.
31. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. Journal of Immunology 1997, 158:3603.
32. Karlhofer F.M., Ribaudo R.K., Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992, 358:66.
33. Karnam G., Rygiel T.P., Raaben M., Grinwis G.C., Coenjaerts F.E., Ressing M.E., et al. CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathogens 2012, 8:e1002710.
34. Kretz-Rommel A., Qin F., Dakappagari N., Cofiell R., Faas S.J., Bowdish K.S. Blockade of CD200 in the presence or absence of antibody effector function: Implications for anti-CD200 therapy. Journal of Immunology 2008, 180:699.
35. Kubagawa H., Burrows P.D., Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:5261.
36. Kubagawa H., Chen C.C., Ho L.H., Shimada T.S., Gartland L., Mashburn C., et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. The Journal of Experimental Medicine 1999, 189:309.
37. Kuroki K., Furukawa A., Maenaka K. Molecular recognition of paired receptors in the immune system. Frontiers in Microbiology 2012, 3:429.
38. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:1315.
39. Langlais C.L., Jones J.M., Estep R.D., Wong S.W. Rhesus rhadinovirus R15 encodes a functional homologue of human CD200. Journal of Virology 2006, 80:3098.
40. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5199.
41. Long E.O. Regulation of immune responses through inhibitory receptors. Annual Review of Immunology 1999, 17:875.
42. McVicar D.W., Taylor L.S., Gosselin P., Willette-Brown J., Mikhael A.I., Geahlen R.L., et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. The Journal of Biological Chemistry 1998, 273:32934.
43. Mihrshahi R., Barclay A.N., Brown M.H. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. Journal of Immunology 2009, 183:4879.
44. Mihrshahi R., Brown M.H. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. Journal of Immunology 2010, 185:7216.
45. Misstear K., Chanas S.A., Rezaee S.A., Colman R., Quinn L.L., Long H.M., et al. Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200. Journal of Virology 2012, 86:6246.
46. Mukhopadhyay S., Pluddemann A., Hoe J.C., Williams K.J., Varin A., Makepeace K., et al. Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. Cell Host & Microbe 2010, 8:236.
47. Nakamura A., Kobayashi E., Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nature Immunology 2004, 5:623.
48. Nakayama M., Underhill D.M., Petersen T.W., Li B., Kitamura T., Takai T., et al. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. Journal of Immunology 2007, 178:4250.
49. Odorizzi P.M., Wherry E.J. Inhibitory receptors on lymphocytes: Insights from infections. Journal of Immunology 2012, 188:2957.
50. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84.
51. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997, 386:514.
52. Rosenblum M.D., Olasz E., Woodliff J.E., Johnson B.D., Konkol M.C., Gerber K.A., et al. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 2004, 103:2691.
53. Sarangi P.P., Woo S.R., Rouse B.T. Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction. Clinical Immunology 2009, 131:31.
54. Shiratori I., Yamaguchi M., Suzukawa M., Yamamoto K., Lanier L.L., Saito T., et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. Journal of Immunology 2005, 175:4441.
55. Shlapatska L.M., Mikhalap S.V., Berdova A.G., Zelensky O.M., Yun T.J., Nichols K.E., et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. Journal of Immunology 2001, 166:5480.
56. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8826.
57. Snelgrove R.J., Goulding J., Didierlaurent A.M., Lyonga D., Vekaria S., Edwards L., et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nature Immunology 2008, 9:1074.
58. Soberman R.J., MacKay C.R., Vaine C.A., Ryan G.B., Cerny A.M., Thompson M.R., et al. CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2. PLoS One 2012, 7:e47740.
59. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J.W., Pla M., et al. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. Journal of Immunology 2000, 164:5019.
60. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). The Journal of Experimental Medicine 1998, 188:1841.
61. Vely F., Vivier E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. Journal of Immunology 1997, 159:2075.
62. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:13483.
63. Voigt S., Mesci A., Ettinger J., Fine J.H., Chen P., Chou W., et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 2007, 26:617.
64. Voigt S., Sandford G.R., Ding L., Burns W.H. Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus. Journal of Virology 2001, 75:603.
65. Weikert B.C., Blumberg E.A. Viral infection after renal transplantation: Surveillance and management. Clinical Journal of the American Society of Nephrology 2008, 3(2):S76.
66. Willcox B.E., Thomas L.M., Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nature Immunology 2003, 4:913.
67. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. Journal of Immunology 2003, 171:3034.
68. Wright G.J., Puklavec M.J., Willis A.C., Hoek R.M., Sedgwick J.D., Brown M.H., et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000, 13:233.
69. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626.
70. Yu K., Chen Z., Gorczynski R. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients. Immunology Letters 2013, 149:1.
71. Zhang S., Cherwinski H., Sedgwick J.D., Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. Journal of Immunology 2004, 173:6786.
72. Zhang S., Phillips J.H. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. Journal of Leukocyte Biology 2006, 79:363.
73. Zhang L., Stanford M., Liu J., Barrett C., Jiang L., Barclay A.N., et al. Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200). Journal of Virology 2009, 83:9602.